Zuellig Pharma has today officially launched Zuellig Health Solutions (ZHS), a new Singapore-based innovation centre, established with the support of the Singapore Economic Development Board (EDB).
Zuellig Pharma will invest over $50m in ZHS over the next five years to develop data, digital and disease management solutions that will help doctors develop more effective treatment plans, support patients managing chronic conditions and help payers manage healthcare costs. These solutions will also help healthcare companies identify market opportunities and reach more patients and consumers across Asia.
ZHS will employ more than 50 Singapore-based healthcare, technology and data specialists and follows the recent relocation of the company’s headquarters from Hong Kong to Singapore.